Biosimilars: Review of regulatory, manufacturing, analytical aspects and beyond

Ratih, Ratih and Asmari, Mufarreh and Abdel-Megied, Ahmed M. and Elbarbry, Fawzy and Deeb., Sami El (2021) Biosimilars: Review of regulatory, manufacturing, analytical aspects and beyond. Microchemical Journal, 165. ISSN 0026-265X

PDF Ratih_Biosimilars.pdf Download (6MB)

Abstract

Biologics have more complex production processes compared to small-molecule drugs. They may even prove labile when drifting from batch-to-batch or in different production locations. The development of new similar biological product was regulated early to face the relevant challenges of this industry. As a result, since 2006 biosimilars were introduced to biotechnology arena with a massive competition in pharmaceutical industry. In this review, the aspects related to similarity testing of biosimilars to the original biological products are discussed involving manufacturing challenges to ensure the quality, safety, and efficacy of these products to the patient health. Immunogenicity studies are highlighted as an important part of the safety assessments. Additionally, several analytical methods that are usually used to evaluate biosimilars in comparison to their reference biologic are summarized and categorized in terms of the intended physicochemical and biological characterization. On the other hand, the international efforts of several regulatory agencies including the European Medicines Agency, World Health Organization and United States Food and Drug Administration for biosimilar development are discussed according to updated revised guidelines.

Item Type:	Article
Uncontrolled Keywords:	BiologicsBiosimilarsBiobettersStepwise comparabilityAnalytical aspects
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Faculty of Pharmacy > Department of Pharmacy
Depositing User:	Eko Setiawan 194014
Date Deposited:	16 Jul 2021 10:22
Last Modified:	06 Oct 2023 03:31
URI:	http://repository.ubaya.ac.id/id/eprint/39819

Actions (login required)

View Item